Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/NC/Hickory
Updated November 2026 from ClinicalTrials.gov

Paid Clinical Trials in Hickory, NC

Studies commonly pay $75 to $4,500 per completed study

96 clinical trials are currently recruiting participants within 30 miles of Hickory. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

96studies recruiting
9+research centers nearby
7condition categories
Live from the NIH registry

Studies recruiting near Hickory right now

Top 25 of 96 recruiting studies, sorted by proximity — each links to its official registry page

Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

Depressive Disorder, Major Phase 3 Interventional 752 participants sought
IMA Clinical Research PC 3 — Hickory, North Carolina (1.2 mi) · Sponsor: Janssen Research & Development, LLC

Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD

COPD, Chronic Obstructive Pulmonary Disease N/A Interventional 200 participants sought
Wake Forest School of Medicine — Salem, North Carolina (21.2 mi) · Sponsor: Nuvaira, Inc.

A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis

Plaque Psoriasis Phase 3 Interventional 366 participants sought
Local Institution - 0234 — Hickory, North Carolina (1.2 mi) · Sponsor: Bristol-Myers Squibb

A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled Gout

Uncontrolled Gout Phase 3 Interventional 270 participants sought
Research Carolina Elite — Denver, North Carolina (21.9 mi) · Sponsor: Amgen

A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM

Weight Management Phase 3 Interventional 4,500 participants sought
Research Site — Statesville, North Carolina (24.6 mi) · Sponsor: AstraZeneca

Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer

Locally Advanced Pancreatic Adenocarcinoma, Stage III Pancreatic Cancer AJCC v8 Phase 1, Phase 2 Interventional 92 participants sought
Wake Forest Baptist Health - Wilkes Medical Center — Wilkesboro, North Carolina (29.4 mi) · Sponsor: National Cancer Institute (NCI)

mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma Phase 3 Interventional 382 participants sought
Wake Forest Baptist Health - Wilkes Medical Center — Wilkesboro, North Carolina (29.4 mi) · Sponsor: Alliance for Clinical Trials in Oncology

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
Novant Health Cancer Institute - Statesville — Statesville, North Carolina (24.6 mi) · Sponsor: SWOG Cancer Research Network

A Study of XB628 Alone and in Combination With Zanzalintinib in Participants With Recurrent Advanced or Metastatic Solid Tumors

Solid Tumor, Advanced Solid Tumor Phase 1 Interventional 303 participants sought
Exelixis Clinical Site #1 — Hickory, North Carolina (1.2 mi) · Sponsor: Exelixis

A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine

Acute Treatment of Migraine Phase 1 Interventional 16 participants sought
Accellacare - Piedmont — Statesville, North Carolina (24.6 mi) · Sponsor: Pfizer

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

High Risk Cardiovascular Disease, Hypertension Phase 3 Interventional 11,000 participants sought
Clinical Trial Site — Statesville, North Carolina (24.6 mi) · Sponsor: Alnylam Pharmaceuticals

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Stage I Breast Cancer Phase 3 Interventional 1,670 participants sought
Novant Health Cancer Institute - Statesville — Statesville, North Carolina (24.6 mi) · Sponsor: NRG Oncology

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Diabetes Mellitus, Type 2, Hypertension Phase 3 Interventional 11,800 participants sought
IMA Clinical Research Lenoir — Lenoir, North Carolina (17.0 mi) · Sponsor: Boehringer Ingelheim

A Study to Investigate IGT-303 in Healthy Volunteers and Participants With Chronic Kidney Disease

Healthy Volunteers, Chronic Kidney Disease Phase 1, Phase 2 Interventional 94 participants sought
Piedmont HealthCare — Statesville, North Carolina (24.6 mi) · Sponsor: Ingenia Therapeutics INC

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

COPD (Chronic Obstructive Pulmonary Disease) Phase 3 Interventional 5,250 participants sought
Research Site — Statesville, North Carolina (24.6 mi) · Sponsor: AstraZeneca

Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials

Breast Cancer, NOS, CNS Primary Tumor, NOS N/A Interventional 400 participants sought
CaroMont Health - Lincoln Cancer Center — Lincolnton, North Carolina (18.9 mi) · Sponsor: Eastern Cooperative Oncology Group

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

Refractory Rheumatoid Arthritis (RA), Idiopathic Inflammatory Myopathies (IIMs) Phase 2 Interventional 90 participants sought
Artiva Investigational Site Statesville — Statesville, North Carolina (24.6 mi) · Sponsor: Artiva Biotherapeutics, Inc.

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Atherosclerotic Cardiovascular Disease, Overweight Phase 3 Interventional 12,800 participants sought
Burke Primary Care Family Practice — Morganton, North Carolina (20.3 mi) · Sponsor: Amgen

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

Chronic Obstructive Pulmonary Disease Phase 3 Interventional 942 participants sought
Advanced Respiratory and Sleep Medicine - Hickory- Site Number : 8400013 — Hickory, North Carolina (1.2 mi) · Sponsor: Sanofi

Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

Lung Non-Small Cell Carcinoma Phase 3 Interventional 336 participants sought
Atrium Health Lincoln/LCI-Lincolnton — Lincolnton, North Carolina (18.9 mi) · Sponsor: National Cancer Institute (NCI)

A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight

Obesity, Type 2 Diabetes Phase 3 Interventional 2,500 participants sought
Piedmont Healthcare/Research — Statesville, North Carolina (24.6 mi) · Sponsor: Novo Nordisk A/S

An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia

Schizophrenia Phase 3 Interventional 280 participants sought
Local Institution - 176 — Hickory, North Carolina (1.2 mi) · Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Actively enrolling

Studies you may be able to join near Hickory

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Google-rated

Top-rated research centers in Hickory

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

PMG Research of Hickory

★ 5.0
221 13th Ave Pl NW Unit 201, Hickory, NC 28601
(828) 345-5060
"A great staff with innovative research team. Research group with new medicines tryed on volunteers. Why wait 20 years for approval of medicines? if q…"
— Donna r, 5★

IMA Clinical Research

★ 5.0
24 2nd Ave NE Ste 204, Hickory, NC 28601
(828) 322-3222
"Great place and the people there are very attentive to your concerns."
— Miguel Montoya, 5★

Clinical Trials of America

10 3rd Ave NE #400, Hickory, NC 28601
(828) 322-3222

Piedmont Endocrinology

★ 4.6
311 9th Ave Dr NE, Hickory, NC 28601
(828) 322-7338

Clinical Research of Gastonia

1010 X Ray Dr # A, Gastonia, NC 28054
(704) 675-7144

Rose Research Center

★ 4.9
8401 Medical Plaza Dr #275, Charlotte, NC 28262
(704) 350-2999
"I had an excellent experience I am definitely team Mary Beth and team rejoice definitely five stars for the ladies"
— Griselda Crawford, 5★

DelRicht Research | Charlotte Clinical Trials

★ 4.8
6719 Fairview Rd Ste A, Charlotte, NC 28210
(704) 644-8469
"The team members are kind and considerate. They will answer questions and provide you with feedback you can share with your primary provider. Super P…"
— Kenya Davis, 5★

Queen City Clinical Research, PLLC

330 Billingsley Rd Ste 206?, Charlotte, NC 28211
(704) 405-3150

New Hope Clinical Research, Inc.

★ 4.2
3101 Latrobe Dr, Charlotte, NC 28211
(980) 209-9784
"They called to screen me and I’m not even depressed. Just lied because I need the money. I’m sure they haven’t called a bunch of others like they cal…"
— Pluto Enterprises LLC, 3★

Clinical trials in Hickory: what's recruiting

The Hickory area currently has 96 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Hickory, the most active research areas are:

  • Cancer & Oncology9 studies
  • Diabetes & Metabolism4 studies
  • Lungs & Breathing3 studies
  • Heart & Vascular3 studies
  • Brain & Mental Health2 studies

Every listing shows the study phase, the recruiting site and its distance from Hickory, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Hickory

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Hickory participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Hickory pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Are clinical trials in Hickory safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Hickory, NC?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Hickory typically complete one or two studies per year.

Paid clinical trials near Hickory

Other metros within reach

By condition

Eligibility and exclusions, condition by condition

More of NC

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

Get free trial alerts